Joost M. Meijer

Groningen, GR, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

Clinical Characterization and Outcomes of Dupilumab for Pemphigoid Gestationis: A Case Series of Five Patients and Literature Review.

Clinical Characterization and Outcomes of Dupilumab for Pemphigoid Gestationis: A Case Series of Five Patients and Literature Review.

Journal: Acta dermato-venereologica

Published: May 07, 2026

Diagnosis and management of anti-p200 pemphigoid: Perspectives of international dermatologists with expertise in immunobullous diseases.

Diagnosis and management of anti-p200 pemphigoid: Perspectives of international dermatologists with expertise in immunobullous diseases.

Journal: Journal of the American Academy of Dermatology

Published: April 24, 2026

Rituximab resistant pemphigus vulgaris successfully treated with obinutuzumab.

Rituximab resistant pemphigus vulgaris successfully treated with obinutuzumab.

Journal: JAAD case reports

Published: December 25, 2025

Emerging Treatments in Pemphigus: Is Healing an Achievable Goal?

Emerging Treatments in Pemphigus: Is Healing an Achievable Goal?

Journal: American journal of clinical dermatology

Published: December 04, 2025

VEXAS syndrome as an underlying cause of disease in patients with Sweet syndrome.

VEXAS syndrome as an underlying cause of disease in patients with Sweet syndrome.

Journal: JAAD case reports

Published: December 03, 2025

International development of Investigator Global Assessment scores for pemphigus.

International development of Investigator Global Assessment scores for pemphigus.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: November 27, 2025

Patient Perspectives on Treatment Outcomes and Priorities in Autoimmune Bullous Diseases: An Exploratory Survey among Dutch Patients.

Patient Perspectives on Treatment Outcomes and Priorities in Autoimmune Bullous Diseases: An Exploratory Survey among Dutch Patients.

Journal: Dermatology (Basel, Switzerland)

Published: November 17, 2025

Clinical Phenotype Transition in Pemphigus May Suggest Undertreatment with Rituximab: Findings from a Retrospective Single-Centre Analysis of Relapsed Patients.

Clinical Phenotype Transition in Pemphigus May Suggest Undertreatment with Rituximab: Findings from a Retrospective Single-Centre Analysis of Relapsed Patients.

Journal: Dermatology (Basel, Switzerland)

Published: August 26, 2025

European S2k guidelines on management of autoimmune blistering diseases in children and adolescents.

European S2k guidelines on management of autoimmune blistering diseases in children and adolescents.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: July 21, 2025

Pemphigoid diseases as immune-related adverse effect following immune checkpoint inhibitors: A clinical case series of a diverse spectrum.

Pemphigoid diseases as immune-related adverse effect following immune checkpoint inhibitors: A clinical case series of a diverse spectrum.

Journal: JAAD case reports

Published: June 20, 2025

Navigating challenges in clinical trials for bullous pemphigoid and pemphigus: learnings from the clinical trial graveyard and an international expert survey.

Navigating challenges in clinical trials for bullous pemphigoid and pemphigus: learnings from the clinical trial graveyard and an international expert survey.

Journal: The British journal of dermatology

Published: April 19, 2025

Bullous and Nonbullous Pemphigoid Associated With Prurigo Nodularis: Successful Treatment With Dupilumab.

Bullous and Nonbullous Pemphigoid Associated With Prurigo Nodularis: Successful Treatment With Dupilumab.

Journal: International journal of dermatology

Published: March 28, 2025

Showing 1-12 of 56

Last Updated: 09/26/2026